{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:52:32Z","timestamp":1791078752348,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.bone.2009.05.008","type":"journal-article","created":{"date-parts":[[2009,5,19]],"date-time":"2009-05-19T09:55:20Z","timestamp":1242726920000},"page":"406-413","source":"Crossref","is-referenced-by-count":117,"title":["Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: An analysis of 31 cases with confocal laser scanning microscopy"],"prefix":"10.1016","volume":"45","author":[{"given":"G.","family":"Favia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.P.","family":"Pilolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Maiorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2009.05.008_bib1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0889-8529(02)00079-8","article-title":"Bisphosphonates","volume":"32","author":"McClung","year":"2003","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"10.1016\/j.bone.2009.05.008_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","article-title":"Bisphosphonates: a review of their pharmacokinetic properties","volume":"18","author":"Lin","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.05.008_bib3","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/annonc\/mdg401","article-title":"The antineoplastic role of bisphosphonates: from basic research to clinical evidence","volume":"14","author":"Santini","year":"2003","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bone.2009.05.008_bib4","first-page":"2949","article-title":"Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases","volume":"60","author":"Boissier","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2009.05.008_bib5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1172\/JCI118841","article-title":"Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro","volume":"98","author":"van der Pluijm","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2009.05.008_bib6","first-page":"3890","article-title":"Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices","volume":"57","author":"Boissier","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2009.05.008_bib7","first-page":"2602","article-title":"Bisphosphonate treatment inhibits the growth of prostate cancer cells","volume":"61","author":"Lee","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2009.05.008_bib8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/sj.bjc.6600476","article-title":"The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro","volume":"87","author":"Riebeling","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bone.2009.05.008_bib9","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bone.2009.05.008_bib10","first-page":"2893","article-title":"Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients","volume":"9","author":"Santini","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bone.2009.05.008_bib11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJM199903043400914","article-title":"\u03b3\/\u03b4 T cell stimulation by pamidronate","volume":"340","author":"Kunzmann","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2009.05.008_bib12","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.bone.2009.05.008_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1634\/theoncologist.9-90004-28","article-title":"Safety of intravenous and oral bisphosphonates and compliance with dosing regimens","volume":"9","author":"Conte","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.bone.2009.05.008_bib14","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1200\/JCO.2001.19.14.3434","article-title":"Safety and efficacy of bisphosphonates beyond 24\u00a0months in cancer patients","volume":"19","author":"Ali","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bone.2009.05.008_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.amjmed.2004.04.015","article-title":"Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity","volume":"117","author":"Lugassy","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bone.2009.05.008_bib16","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral. Maxillofac. Surg."},{"key":"10.1016\/j.bone.2009.05.008_bib17","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphanates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bone.2009.05.008_bib18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J. Oral. Maxillofac. Surg."},{"key":"10.1016\/j.bone.2009.05.008_bib19","first-page":"111","article-title":"Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy","volume":"71","author":"Melo","year":"2005","journal-title":"J. Can. Dent. Assoc."},{"key":"10.1016\/j.bone.2009.05.008_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tripleo.2004.08.001","article-title":"Intravenous bisphosphonates and osteonecrosis","volume":"98","author":"Greenberg","year":"2004","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod."},{"key":"10.1016\/j.bone.2009.05.008_bib21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5694\/j.1326-5377.2005.tb06762.x","article-title":"Bisphosphonates and osteonecrosis of the jaw","volume":"182","author":"Purcell","year":"2005","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.bone.2009.05.008_bib22","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.joms.2005.06.003","article-title":"Bisphosphonate-associated osteonecrosis of the jaws","volume":"63","author":"Schwartz","year":"2005","journal-title":"J. Oral. Maxillofac. Surg."},{"key":"10.1016\/j.bone.2009.05.008_bib23","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2141.2005.05382.x","article-title":"Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma","volume":"128","author":"Vannucchi","year":"2005","journal-title":"Br. J. Hematol."},{"key":"10.1016\/j.bone.2009.05.008_bib24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0714.2004.00269.x","article-title":"Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases","volume":"34","author":"Bagan","year":"2005","journal-title":"J. Oral. Pathol. Med."},{"key":"10.1016\/j.bone.2009.05.008_bib25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.joms.2005.01.010","article-title":"Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?","volume":"63","author":"Hellstein","year":"2005","journal-title":"J. Oral. Maxillofac. Surg."},{"key":"10.1016\/j.bone.2009.05.008_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Maerevoet","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2009.05.008_bib27","first-page":"100","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2009.05.008_bib28","first-page":"100","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Woo","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2009.05.008_bib29","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.14219\/jada.archive.2006.0355","article-title":"Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations","volume":"137","year":"2006","journal-title":"J. Am. Dent. Assoc."},{"key":"10.1016\/j.bone.2009.05.008_bib30","first-page":"898","article-title":"Bone mineral density and bone histomorphometry are statistically related","volume":"20","author":"Todisco","year":"2005","journal-title":"Int. J. Oral. Maxillofac. Implants"},{"key":"10.1016\/j.bone.2009.05.008_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/01913120802397836","article-title":"New approach for static bone histomorphometry: confocal laser scanning microscopy of maxilla-facial normal bone","volume":"32","author":"Pilolli","year":"2008","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.bone.2009.05.008_bib32","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.05.008_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF02554966","article-title":"The structure of the trabeculae of cancellous bone. 2. Long bones and mastoid","volume":"46","author":"Lozupone","year":"1990","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2009.05.008_bib34","doi-asserted-by":"crossref","unstructured":"Greiner S., Kadow-Romacker A., Schmidmaier G., Wildemann B., Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating. J Biomed Mater Res A, doi:10.1002\/jbm.a.32245.","DOI":"10.1002\/jbm.a.32245"},{"key":"10.1016\/j.bone.2009.05.008_bib35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jinorgbio.2008.09.012","article-title":"Alendronate and Pamidronate calcium phosphate bone cements: setting properties and in vitro response of osteoblast and osteoclast cells","volume":"103","author":"Panzavolta","year":"2009","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bone.2009.05.008_bib36","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.joms.2007.12.004","article-title":"Histomorphometric evaluation of the effects of zoledronic acid on mandibular distraction osteogenesis in rabbits","volume":"66","author":"Pampu","year":"2008","journal-title":"J. Oral. Maxillofac. Surg."},{"key":"10.1016\/j.bone.2009.05.008_bib37","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.biomaterials.2007.10.040","article-title":"Alendronate-hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells","volume":"29","author":"Boanini","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.bone.2009.05.008_bib38","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI119668","article-title":"Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis","volume":"100","author":"Chavassieux","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2009.05.008_bib39","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jc.2005-0057","article-title":"Long-term safety of bisphosphonates","volume":"90","author":"Ott","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2009.05.008_bib40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/jcp.37.4.398","article-title":"When is it an osteoclast?","volume":"37","author":"Kaye","year":"1984","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bone.2009.05.008_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.bone.2009.05.008_bib42","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1172\/JCI200422087","article-title":"An amino-bisphosphonates targets MMP-9 expressing macrophages and angiogenesis to impair cervical carcinogenesis","volume":"114","author":"Giraudo","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2009.05.008_bib43","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1359\/jbmr.2002.17.6.998","article-title":"Dissociation of angiogenesis and octeoclastogenesis during endochondral bone formation in neonatal mice","volume":"17","author":"Deckers","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.05.008_bib44","first-page":"1080","article-title":"Pamidronate induces modification of circulating angiogenetic factors in cancer patients","volume":"8","author":"Santini","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bone.2009.05.008_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1067\/moe.2003.25","article-title":"Osteomyelitis of the maxilla secondary to osteopetrosis: report of a case","volume":"95","author":"Barry","year":"2003","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod."},{"key":"10.1016\/j.bone.2009.05.008_bib46","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.joms.2003.09.001","article-title":"Avascular necrosis of the jaws: risk factors in metastatic cancer patients","volume":"61","author":"Tarassoff","year":"2003","journal-title":"J. Oral. Maxillofac. Surg."},{"key":"10.1016\/j.bone.2009.05.008_bib47","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2009.05.008_bib48","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/1097-0142(19810415)47:8<1980::AID-CNCR2820470813>3.0.CO;2-Y","article-title":"Osteonecrosis in patients irradiated for head and neck carcinoma","volume":"47","author":"Morrish","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.bone.2009.05.008_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/154411130201300104","article-title":"Destructive periodontitis lesions are determined by the nature of the lymphocytic response","volume":"13","author":"Gemmell","year":"2002","journal-title":"Crit. Rev. Oral. Biol. Med."},{"key":"10.1016\/j.bone.2009.05.008_bib50","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years' experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2009.05.008_bib51","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00428-006-0261-y","article-title":"Increased numbers of osteoclasts expressing cysteine proteinase cathepsin K in patients with infected osteoradionecrosis and bisphosphonate-associated osteonecrosis \u2014 a paradoxical observation?","volume":"449","author":"Hansen","year":"2006","journal-title":"Virchows Arch."},{"issue":"3","key":"10.1016\/j.bone.2009.05.008_bib52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","article-title":"Osteonecrosis of the jaws in patients treated with bisphosphonates \u2014 histomorphologic analysis in comparison with infected osteoradionecrosis","volume":"35","author":"Hansen","year":"2006","journal-title":"J. Oral. Pathol. Med."},{"issue":"3","key":"10.1016\/j.bone.2009.05.008_bib53","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tripleo.2007.08.040","article-title":"Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology","volume":"105","author":"Bedogni","year":"2008","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328209015993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328209015993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T10:43:03Z","timestamp":1589798583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328209015993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S8756328209015993"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2009.05.008","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}